Skip to main content
. 2024 Nov 20;16(11):500. doi: 10.3390/toxins16110500

Figure 1.

Figure 1

(A) shows the percentage of the type of botulinum toxin used in the literature, while (B) shows the research design of the articles examined in this review. (C) describes the dilution, and (D) represents the distribution of injection approaches used in the articles examined. Legend: NA—not available; IM—intramuscular; SC—subcutaneous; ID—intradermal; IO—intraoral.